Cargando…
Suppression of metallothionein-I/II expression and its probable molecular mechanisms.
Metallothionein (MT) promoter was methylated in rat hepatoma and in mouse lymphosarcoma cells by methylation of cytosine within the CpG dinucleotide region. After demethylation of MT-I promoter in mouse lymphosarcoma cells or in the transplanted rat hepatoma with 5-azacytidine, a potent inhibitor of...
Autores principales: | Jacob, Samson T, Majumder, Sarmila, Ghoshal, Kalpana |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
2002
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1241254/ https://www.ncbi.nlm.nih.gov/pubmed/12426140 |
Ejemplares similares
-
TGFβ mediated upregulation of hepatic miR-181b promotes hepatocarcinogenesis by targeting TIMP3
por: Wang, Bo, et al.
Publicado: (2009) -
Increased Metallothionein I/II Expression in Patients with Temporal Lobe Epilepsy
por: Peixoto-Santos, José Eduardo, et al.
Publicado: (2012) -
HOXB13, a Target of DNMT3B, Is Methylated at an Upstream CpG Island, and Functions as a Tumor Suppressor in Primary Colorectal Tumors
por: Ghoshal, Kalpana, et al.
Publicado: (2010) -
Correction: Increased Metallothionein I/II Expression in Patients with Temporal Lobe Epilepsy
por: Peixoto-Santos, José Eduardo, et al.
Publicado: (2016) -
Focusing on the protective effects of metallothionein-I/II in cerebral ischemia
por: Eidizadeh, Abass, et al.
Publicado: (2016)